By analyzing the clinicopathological characteristics and clinical outcomes of the 48 HCC patients, we discovered that the expression of FABP5 was closely related to tumor staging and postoperative metastasis (Table 1, p < .05). The gene discussed is FABP5; the disease is hepatocellular carcinoma.